A day-to-day management model improves patient compliance to treatment for Helicobacter pylori infection: a prospective, randomized controlled study.
A day-to-day management model improves patient compliance to treatment for Helicobacter pylori infection: a prospective, randomized controlled study.
复制标题
DOI：
10.1186/s13099-023-00556-x
复制
发表时间：
2023-07-31
期刊：
影响因子：
4.2
通讯作者：
中科院分区：
文献类型：
--
作者：
The day-to-day (DTD) management model encourages patients to actively participate in their healthcare by setting goals. We determined the effectiveness of the DTD model in the treatment of Helicobacter pylori (H. pylori) infection, as compared with conventional outpatient education (OE). We randomized 254 H. pylori-positive patients into a DTD group (127 patients) and an OE group (127 patients) prior to primary treatment with 14-day bismuth-containing quadruple therapy, including esomeprazole, amoxicillin, and clarithromycin. Both groups received consistent medication instructions. Patients in the DTD group recorded daily attendance after completing their daily medication plan from day 1 to day 14. The medication compliance, follow-up compliance, H. pylori eradication rates, and adverse events (AEs) were evaluated. In the modified intention-to-treat (MITT) and per-protocol (PP) analyses, the DTD group showed significantly higher medication compliance than the OE group (P = 0.001 and P = 0.031, respectively). Both the MITT and PP analyses showed significant differences in follow-up compliance (P < 0.001 and P = 0.003, respectively) and timing of the review urea breath test (P < 0.001 and P = 0.001, respectively) between the two groups. However, no significant differences were observed in the H. pylori eradication rates (95.8% vs. 93.8%, P = 0.529) in the PP analysis, or AEs incidence (25.4% vs. 28.3%, P = 0.603) between the two groups. This study demonstrated the novel application of the DTD model in the treatment of H. pylori infection, which enabled patients to develop habitual medication-taking behaviors without physician intervention. The online version contains supplementary material available at 10.1186/s13099-023-00556-x.
登录
查看更多内容
影响因子：
2.4
作者：
Sun, Kefang;Chen, Yishu;Wang, Zhenzhen;Liu, Yi;Pan, Yue;Mao, Xinli;Xu, Lei;Jin, Chaohui;Chen, Ming;Yu, Chaohui;Li, Lan
通讯作者：
Li, Lan
影响因子：
3.5
作者：
Lin, Bo Shen;Li, Yue Yue;Li, Yan Qing
通讯作者：
Li, Yan Qing
影响因子：
24.5
作者：
Zhou, Xian-Zhu;Lyu, Nong-Hua;Zhu, Hui-Yun;Cai, Quan-Cai;Kong, Xiang-Yu;Xie, Pei;Zhou, Li-Ya;Ding, Song-Ze;Li, Zhao-Shen;Du, Yi-Qi
通讯作者：
Du, Yi-Qi
影响因子：
29.4
作者：
Shah SC;Iyer PG;Moss SF
通讯作者：
Moss SF
影响因子：
4.4
作者：
Luo, Miaomiao;Hao, Yu;Chen, Weigang
通讯作者：
Chen, Weigang